Year: 2015
Resolution Number: 64
Action Taken: Approved as Amended
Status:
Author(s): James Randolph Hillard, MD
Sponsor: James Randolph Hillard, MD
On behalf of:
Committee: A (Medical Care Delivery)
Resolved Section(s):
RESOLVED: That MSMS support state and federal legislation, similar to that passed in a majority of states, mandating parity between intravenous medications and oral anti-cancer therapy drugs.
RESOLVED: That MSMS support state and federal legislation, similar to that passed in a majority of states, mandating parity between intravenous medications and oral anti-cancer therapy drugs.
Fiscal Note: NULL
Resolution: View PDF for Oral Anti-Cancer Therapy Drug Parity
For More Information, Contact: